Comment on 'MicroRNA-199b-5p attenuates TGF-β1-induced epithelial-mesenchymal transition in hepatocellular carcinoma'.
作者信息
Cristóbal Ion, Santos Andrea, González Silvia, Luque Melania, Torrejón Blanca, Rojo Federico, García-Foncillas Jesús
机构信息
Translational Oncology Division, Oncohealth Institute, IIS-Fundacion Jimenez Diaz-UAM, University Hospital "Fundacion Jimenez Diaz", Madrid, Spain.
Pathology Department, IIS-Fundacion Jimenez Diaz-UAM, University Hospital "Fundacion Jimenez Diaz", Madrid, Spain.
出版信息
Br J Cancer. 2018 Apr;118(7):1028-1029. doi: 10.1038/s41416-018-0013-1. Epub 2018 Mar 19.
Abstract
摘要
相似文献
1
Comment on 'MicroRNA-199b-5p attenuates TGF-β1-induced epithelial-mesenchymal transition in hepatocellular carcinoma'.
Br J Cancer. 2018 Apr;118(7):1028-1029. doi: 10.1038/s41416-018-0013-1. Epub 2018 Mar 19.
2
Reply to 'Comment on 'MicroRNA-199b-5p attenuates TGF-β1-induced epithelial-mesenchymal transition in hepatocellular carcinoma''.
Br J Cancer. 2018 Apr;118(7):1030. doi: 10.1038/s41416-018-0031-z. Epub 2018 Mar 19.
3
MicroRNA-199b-5p attenuates TGF-β1-induced epithelial-mesenchymal transition in hepatocellular carcinoma.
Br J Cancer. 2017 Jul 11;117(2):233-244. doi: 10.1038/bjc.2017.164. Epub 2017 Jun 6.
4
Combined treatment with zingerone and its novel derivative synergistically inhibits TGF-β1 induced epithelial-mesenchymal transition, migration and invasion of human hepatocellular carcinoma cells.
Bioorg Med Chem Lett. 2017 Feb 15;27(4):1081-1088. doi: 10.1016/j.bmcl.2016.12.042. Epub 2016 Dec 20.
5
miR-133b and miR-199b knockdown attenuate TGF-β1-induced epithelial to mesenchymal transition and renal fibrosis by targeting SIRT1 in diabetic nephropathy.
Eur J Pharmacol. 2018 Oct 15;837:96-104. doi: 10.1016/j.ejphar.2018.08.022. Epub 2018 Aug 17.
6
STAT3 aggravates TGF-β1-induced hepatic epithelial-to-mesenchymal transition and migration.
Biomed Pharmacother. 2018 Feb;98:214-221. doi: 10.1016/j.biopha.2017.12.035. Epub 2017 Dec 27.
7
Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma.
Cancer Lett. 2014 Oct 1;352(2):160-8. doi: 10.1016/j.canlet.2014.05.008. Epub 2014 Jun 2.
8
Sphingosine-1-phosphate induced epithelial-mesenchymal transition of hepatocellular carcinoma via an MMP-7/ syndecan-1/TGF-β autocrine loop.
Oncotarget. 2016 Sep 27;7(39):63324-63337. doi: 10.18632/oncotarget.11450.
9
GP73 promotes epithelial-mesenchymal transition and invasion partly by activating TGF-β1/Smad2 signaling in hepatocellular carcinoma.
Carcinogenesis. 2018 Jul 3;39(7):900-910. doi: 10.1093/carcin/bgy010.
10
Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)/Lcn2/Twist1 pathway.
Hepatology. 2013 Oct;58(4):1349-61. doi: 10.1002/hep.26467. Epub 2013 Aug 7.
引用本文的文献
1
Reply to 'Comment on 'MicroRNA-199b-5p attenuates TGF-β1-induced epithelial-mesenchymal transition in hepatocellular carcinoma''.
Br J Cancer. 2018 Apr;118(7):1030. doi: 10.1038/s41416-018-0031-z. Epub 2018 Mar 19.
本文引用的文献
1
SET contributes to the epithelial-mesenchymal transition of pancreatic cancer.
Oncotarget. 2017 Jul 7;8(40):67966-67979. doi: 10.18632/oncotarget.19067. eCollection 2017 Sep 15.
2
MicroRNA-199b-5p attenuates TGF-β1-induced epithelial-mesenchymal transition in hepatocellular carcinoma.
Br J Cancer. 2017 Jul 11;117(2):233-244. doi: 10.1038/bjc.2017.164. Epub 2017 Jun 6.
3
Protein phosphatase 2A regulation of markers of extracellular matrix remodelling in hepatocellular carcinoma cells: functional consequences for tumour invasion.
Br J Pharmacol. 2017 May;174(10):1116-1130. doi: 10.1111/bph.13759. Epub 2017 Apr 7.
4
Downregulation of microRNA-199b predicts unfavorable prognosis and emerges as a novel therapeutic target which contributes to PP2A inhibition in metastatic colorectal cancer.
Oncotarget. 2017 Jun 20;8(25):40169-40180. doi: 10.18632/oncotarget.11174.
5
Upregulation of the oncoprotein SET determines poor clinical outcomes in hepatocellular carcinoma and shows therapeutic potential.
Oncogene. 2016 Sep 15;35(37):4891-902. doi: 10.1038/onc.2016.21. Epub 2016 Feb 15.
6
Overexpression of PP2A inhibitor SET oncoprotein is associated with tumor progression and poor prognosis in human non-small cell lung cancer.
Oncotarget. 2015 Jun 20;6(17):14913-25. doi: 10.18632/oncotarget.3818.
7
Cardamonin Suppresses TGF-β1-Induced Epithelial Mesenchymal Transition via Restoring Protein Phosphatase 2A Expression.
Biomol Ther (Seoul). 2015 Mar;23(2):141-8. doi: 10.4062/biomolther.2014.117. Epub 2015 Mar 1.
8
Stable SET knockdown in breast cell carcinoma inhibits cell migration and invasion.
Biochem Biophys Res Commun. 2014 Oct 10;453(1):7-12. doi: 10.1016/j.bbrc.2014.09.013. Epub 2014 Sep 16.
9
Overexpression of SET is a recurrent event associated with poor outcome and contributes to protein phosphatase 2A inhibition in acute myeloid leukemia.
Haematologica. 2012 Apr;97(4):543-50. doi: 10.3324/haematol.2011.050542. Epub 2011 Dec 1.
10
Synergistic interactions between sorafenib and bortezomib in hepatocellular carcinoma involve PP2A-dependent Akt inactivation.
J Hepatol. 2010 Jan;52(1):88-95. doi: 10.1016/j.jhep.2009.10.011. Epub 2009 Oct 23.
Zotero 插件